Tango Therapeutics, Inc.

Historical 13F Holders

Symbol: TNGX
CUSIP: 87583X109
All holders as of: Q2 2026
Type: Equity
Class: COM

Reported Value, Excluding Options

Total Shares Held, Excluding Options

Total Filers

13D/G Filers

Each filer's latest filing for 87583X109 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
FMR LLC 13G/A	15.0%	25,286,624	13G/A	11/6/2026 Event 10/30/2026
FMR LLC	15.0%	25,286,624
Abigail P. Johnson	15.0%	25,286,624
BCTG Holdings, LLC 13D/A	10.0%	10,740,385	13D/A	1/2/2025 Event 12/30/2024
BCTG Holdings, LLC	0%	0
MVA Investors, LLC	0.3%	326,886
Davis Aaron I.	10.0%	10,740,385
Boxer Capital Management, LLC	9.7%	10,380,999
Farallon Partners L L C/CA 13G/A	10.0%	13,461,215	13G/A	2/6/2026 Event 12/31/2025
Farallon Capital Partners, L.P.	1.6%	2,199,950
Farallon Capital Institutional Partners, L.P.	2.2%	2,922,242
Farallon Capital Institutional Partners II, L.P.	0.5%	710,502
Farallon Capital Institutional Partners III, L.P.	0.4%	496,032
Four Crossings Institutional Partners V, L.P.	0.4%	605,612
Farallon Capital Offshore Investors II, L.P.	3.9%	5,280,943
Farallon Capital (AM) Investors, L.P.	0.3%	359,837
Farallon Capital F5 Master I, L.P.	0.4%	556,097
Farallon Healthcare Partners Master, L.P.	0.2%	330,000
Farallon Partners, L.L.C.	9.6%	12,905,118
Farallon Institutional (GP) V, L.L.C.	0.4%	605,612
Farallon F5 (GP), L.L.C.	0.4%	556,097
Farallon Healthcare Partners (GP), L.L.C.	0.2%	330,000
Dapice Joshua J.	10.0%	13,461,215
Dreyfuss, Philip D.	10.0%	13,461,215
Dunn Hannah E.	10.0%	13,461,215
Fried, Richard B	0%	0
Gehani, Varun N.	10.0%	13,461,215
Giauque, Nicolas	10.0%	13,461,215
Husen, Avner A.	10.0%	13,461,215
Kim, David T.	10.0%	13,461,215
Linn, Michael G.	10.0%	13,461,215
Luo Patrick (Cheng)	10.0%	13,461,215
Patel, Rajiv A.	0%	0
Roberts, Jr., Thomas G.	10.0%	13,461,215
Saito Edric C.	10.0%	13,461,215
Seybold, William	0%	0
Short Daniel S.	10.0%	13,461,215
Spokes, Andrew J. M.	10.0%	13,461,215
Warren, John R.	10.0%	13,461,215
Wehrly, Mark C.	10.0%	13,461,215
Farallon Capital Management, L.L.C. 13G/A	9.8%	16,270,187	13G/A	8/14/2026 Event 6/30/2026
Farallon Capital Management, L.L.C.	9.8%	16,270,187
Farallon Capital Partners, L.P.	0%	0
Farallon Capital Institutional Partners, L.P.	0%	0
Farallon Capital Institutional Partners II, L.P.	0%	0
Farallon Capital Institutional Partners III, L.P.	0%	0
Four Crossings Institutional Partners V, L.P.	0%	0
Farallon Capital Offshore Investors II, L.P.	0%	0
Farallon Capital (AM) Investors, L.P.	0%	0
Farallon Capital F5 Master I, L.P.	0%	0
Farallon Healthcare Partners Master, L.P.	0%	0
Farallon Partners, L.L.C.	0%	0
Farallon Institutional (GP) V, L.L.C.	0%	0
Farallon F5 (GP), L.L.C.	0%	0
Farallon Healthcare Partners (GP), L.L.C.	0%	0
Dapice Joshua J.	9.8%	16,270,187
Dreyfuss, Philip D.	9.8%	16,270,187
Dunn Hannah E.	9.8%	16,270,187
Gehani, Varun N.	9.8%	16,270,187
Giauque, Nicolas	9.8%	16,270,187
Husen, Avner A.	9.8%	16,270,187
Kim, David T.	9.8%	16,270,187
Linn, Michael G.	9.8%	16,270,187
Luo Patrick (Cheng)	9.8%	16,270,187
Roberts, Jr., Thomas G.	9.8%	16,270,187
Saito Edric C.	9.8%	16,270,187
Short Daniel S.	9.8%	16,270,187
Spokes, Andrew J. M.	9.8%	16,270,187
Warren, John R.	9.8%	16,270,187
Wehrly, Mark C.	9.8%	16,270,187
RTW Investments, LP 13G	9.3%	13,300,620	13G	5/15/2026 Event 3/31/2026
RTW Investments, LP	9.3%	13,300,620
Roderick Wong	9.3%	13,300,620
Farallon Capital Partners, L.P. 13G/A	7.8%	11,257,203	13G/A	5/11/2026 Event 3/31/2026
Farallon Capital Partners, L.P.	0.7%	1,055,717
Farallon Capital Institutional Partners, L.P.	1.0%	1,470,591
Farallon Capital Institutional Partners II, L.P.	0.2%	290,563
Farallon Capital Institutional Partners III, L.P.	0.2%	226,033
Four Crossings Institutional Partners V, L.P.	0.2%	260,503
Farallon Capital Offshore Investors II, L.P.	1.7%	2,488,434
Farallon Capital (AM) Investors, L.P.	0.1%	163,734
Farallon Capital F5 Master I, L.P.	0.2%	292,726
Farallon Healthcare Partners Master, L.P.	3.5%	5,008,902
Farallon Partners, L.L.C.	7.6%	10,964,477
Farallon Institutional (GP) V, L.L.C.	0.2%	260,503
Farallon F5 (GP), L.L.C.	0.2%	292,726
Farallon Healthcare Partners (GP), L.L.C.	3.5%	5,008,902
Dapice Joshua J.	7.8%	11,257,203
Dreyfuss, Philip D.	7.8%	11,257,203
Dunn Hannah E.	7.8%	11,257,203
Gehani, Varun N.	7.8%	11,257,203
Giauque, Nicolas	7.8%	11,257,203
Husen, Avner A.	7.8%	11,257,203
Kim, David T.	7.8%	11,257,203
Linn, Michael G.	7.8%	11,257,203
Luo Patrick (Cheng)	7.8%	11,257,203
Roberts, Jr., Thomas G.	7.8%	11,257,203
Saito Edric C.	7.8%	11,257,203
Short Daniel S.	7.8%	11,257,203
Spokes, Andrew J. M.	7.8%	11,257,203
Warren, John R.	7.8%	11,257,203
Wehrly, Mark C.	7.8%	11,257,203
TCG Crossover GP II, LLC 13G/A	7.0%	10,147,867	13G/A	8/14/2026 Event 6/30/2026
TCG Crossover GP II, LLC	7.0%	10,147,867
TCG Crossover Fund II, L.P.	7.0%	10,147,867
Chen Yu	7.0%	10,147,867
BlackRock, Inc. 13G	6.3%	8,477,165	13G	1/21/2026 Event 12/31/2025
Goldman Sachs Group Inc 13G	6.0%	9,742,402.8	13G	8/14/2026 Event 6/30/2026
The Goldman Sachs Group, Inc.	6.0%	9,742,402.8
Goldman Sachs & Co. LLC	6.0%	9,742,402.8
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Third Rock Ventures IV, L.P. 13D/A	4.7%	6,374,574	13D/A	2/10/2026 Event 2/6/2026
Third Rock Ventures IV, L.P.	4.7%	6,374,574
Third Rock Ventures GP IV, L.P.	4.7%	6,374,574
TRV GP IV, LLC	4.7%	6,374,574
Invus Global Management, LLC 13G/A	4.0%	5,657,105	13G/A	5/4/2026 Event 3/31/2026
Invus Public Equities, L.P.	3.5%	4,964,650
Invus Public Equities Advisors, LLC	3.5%	4,964,650
Invus Global Management, LLC	3.5%	4,964,650
Siren, L.L.C.	3.5%	4,964,650
Avicenna Life Sci Master Fund LP	0.5%	692,455
Avicenna Life Sci Master GP LLC	0.5%	692,455
Ulys, L.L.C.	0.5%	692,455
Raymond Debbane	4.0%	5,657,105
Adage Capital Management, L.P. 13G/A	3.4%	5,600,000	13G/A	8/12/2026 Event 6/30/2026
Adage Capital Management, L.P.	3.4%	5,600,000
Robert Atchinson	3.4%	5,600,000
Phillip Gross	3.4%	5,600,000
Woodline Partners LP 13G/A	2.5%	4,000,567	13G/A	8/14/2026 Event 6/30/2026
EcoR1 Capital, LLC 13G/A	0%	0	13G/A	2/17/2026 Event 12/31/2025
EcoR1 Capital, LLC	0%	0
Oleg Nodelman	0%	0
EcoR1 Capital Fund Qualified, L.P.	0%	0
Nextech Crossover I GP S.a r.l. 13G/A	0%	0	13G/A	8/14/2026 Event 6/30/2026
Nextech Crossover I GP S.a. r.l.	0%	0
Nextech Crossover I SCSp	0%	0
Ian Charoub	0%	0
Costas Constantinides	0%	0
Rocco Sgobbo	0%	0
Vanguard Group Inc 13G/A	0%	0	13G/A	3/27/2026 Event 3/13/2026

13F Holders by Quarter

Period	Filers	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	97	28.4 M	$709M	$913k
2026 Q2	249	214 M	$6.60B	$17.5M
2026 Q1	195	180 M	$3.77B	$3.72M
2025 Q4	171	173 M	$1.53B	$735k
2025 Q3	141	140 M	$1.18B	$1.57M
2025 Q2	117	127 M	$652M	$1.35M
2025 Q1	123	107 M	$147M	$1.51k
2024 Q4	139	106 M	$329M	$17.9k
2024 Q3	122	101 M	$781M	$35.4k
2024 Q2	121	98.6 M	$846M	$30.9k
2024 Q1	127	98.4 M	$781M	$28.6k
2023 Q4	122	93.6 M	$927M	$4.95k
2023 Q3	100	88.8 M	$1.00B	$0
2023 Q2	90	68.3 M	$227M	$0
2023 Q1	93	69.8 M	$276M	$0
2022 Q4	83	68.7 M	$498M	$0
2022 Q3	88	68.2 M	$247M	$0
2022 Q2	78	70.5 M	$319M	$0
2022 Q1	73	69.7 M	$528M	$0
2021 Q4	59	67.8 M	$741M	$0
2021 Q3	47	65.5 M	$845M	$0